| Brucella intermedia | |
|---|---|
| Scientific classification | |
| Domain: | Bacteria |
| Kingdom: | Pseudomonadati |
| Phylum: | Pseudomonadota |
| Class: | Alphaproteobacteria |
| Order: | Hyphomicrobiales |
| Family: | Brucellaceae |
| Genus: | Brucella |
| Species: | B. intermedia |
| Binomial name | |
| Brucella intermedia (Velasco et al. 1998) Hördt et al. 2020 [1] | |
| Type strain | |
| BCRC 17247, CCM 7179, CCRC 17247, CCUG 24694, CIP 105838, CL 350/83, CNS 2-75, DSM 17986, IFO 15820, LMG 3301, NBRC 15820, NCTC 12171, VTT E-991166 [2] | |
| Synonyms [3] | |
| |
Brucella intermedia is a bacterium from the genus of Brucella . [4] [5] It was first described by Velasco and others in 1998. [6] It causes diseases in humans only rarely, with single case reports of cholangitis following liver transplantation, [7] bacteremia in a patient with bladder cancer, [8] a pelvic abscess after abdominal surgery, [9] [10] dyspepsia, [11] endophthalmitis in the presence of a foreign body, [12] pneumonia, [13] and endocarditis. [14]
B. intermedia, B. anthropi, and Brucella melitensis can be distinguished on the basis of a multi-primer polymerase chain reaction that targets the recA gene. [15] A genome of B. intermedia was sequenced and submitted to GenBank in 2013. [16]